PMS-IC Supports Research and Progression of Optimal Disease Treatments.

A new fund to support Scottish researchers with accurate diagnosis and/or treatment based on an individual’s unique biology has been launched by Precision Medicine Scotland Innovation Centre (PMS-IC) the national centre for accelerating the advancement and adoption of precision medicine. Funds of up to £30,000 will be available for a maximum of ten projects that will require applicants to demonstrate how their work will advance precision medicine and which will support work involving collaborations with the NHS, academia and industry.

PMS-IC is looking for ideas with a strong case for commercialisation.  It is seeking applicants from a Scottish research funding university or college with an industry partner to provide match funding.  For applicants looking to commercialise current research there must be a strong case of support from a business development specialist.  

Marian McNeil, Chief Executive, Precision Medicine Scotland Innovation Centre, said: “We have designed this fund to help discover new innovation in precision medicine which can be adopted across the NHS in Scotland and the wider global economy.   We are passionate about supporting new talent and we want to provide the impetus to accelerate the adoption of precision medicine in healthcare. Our aim is to support researchers who are already engaged in work that can change and save people’s lives.  

“We look forward to reviewing the high quality project proposals and to helping foster existing ideas that can make use of this fund to transform innovative research into tangible commercial outcomes that benefit patients.”

The deadline for submissions is the 23rd of September and successful applicants will be announced on 26th October.  The Business Development Team at Precision Medicine Scotland will be available to discuss ideas with potential applicants. Details of the fund and forms are available from PMS-IC’s website.

More information online